FDA NDC Directory · JSON-LD · Markdown

Cerdelga

NDC 58468-0220 · HUMAN PRESCRIPTION DRUG · CAPSULE

Generic nameeliglustat
Labeler / ManufacturerGenzyme Corporation
Marketing categoryNew Drug Application (innovator) · App NDA205494
Dosage form / routeCAPSULE · ORAL
Active ingredientsELIGLUSTAT (84 mg/1)
Marketing started20140903
Package count2

External sources

Source: openFDA. Public-domain (CC0).